Antonio de Molina-Iracheta
Overview
Explore the profile of Antonio de Molina-Iracheta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medina-Hernandez D, Cadiz L, Mastrangelo A, Moreno-Arciniegas A, Fernandez Tocino M, Cueto Becerra A, et al.
JACC CardioOncol
. 2025 Feb;
7(2):171-184.
PMID: 39967204
Background: Anthracycline-induced cardiotoxicity (AIC) is characterized by a disruption in myocardial metabolism. Objectives: The authors used a large animal model to test sodium-glucose cotransporter inhibitor therapy to prevent AIC. Methods:...
2.
Galan-Arriola C, Vilchez-Tschischke J, Lobo M, Lopez G, de Molina-Iracheta A, Perez-Martinez C, et al.
Cardiovasc Res
. 2021 Feb;
118(2):531-541.
PMID: 33605403
Aims: The aim of this study was to study changes in coronary microcirculation status during and after several cycles of anthracycline treatment. Methods And Results: Large-white male pigs (n=40) were...
3.
Galan-Arriola C, Villena-Gutierrez R, Higuero-Verdejo M, Diaz-Rengifo I, Pizarro G, Lopez G, et al.
Cardiovasc Res
. 2020 Jun;
117(4):1132-1143.
PMID: 32597960
Aims: Anthracycline-induced cardiotoxicity (AIC) is a serious adverse effect among cancer patients. A central mechanism of AIC is irreversible mitochondrial damage. Despite major efforts, there are currently no effective therapies...
4.
Rossello X, Lopez-Ayala P, Fernandez-Jimenez R, Oliver E, Galan-Arriola C, de Molina-Iracheta A, et al.
Eur Heart J Cardiovasc Imaging
. 2019 Dec;
21(9):1031-1038.
PMID: 31848573
Aims: To assess whether R2* is more accurate than T2* for the detection of intramyocardial haemorrhage (IMH) and to evaluate whether T2' (or R2') is less affected by oedema than...
5.
Galan-Arriola C, Lobo M, Vilchez-Tschischke J, Lopez G, de Molina-Iracheta A, Perez-Martinez C, et al.
J Am Coll Cardiol
. 2019 Feb;
73(7):779-791.
PMID: 30784671
Background: Anthracycline-induced cardiotoxicity is a major clinical problem, and early cardiotoxicity markers are needed. Objectives: The purpose of this study was to identify early doxorubicin-induced cardiotoxicity by serial multiparametric cardiac...
6.
Aguero J, Galan-Arriola C, Fernandez-Jimenez R, Sanchez-Gonzalez J, Ajmone N, Delgado V, et al.
J Am Coll Cardiol
. 2017 Dec;
70(23):2878-2889.
PMID: 29216983
Background: Left atrial (LA) remodeling after an acute myocardial infarction (MI) is poorly characterized regarding its determinants or its effect on ischemic mitral regurgitation (MR) development. Objectives: The purpose of...